#Mounjaro

articles
Eli Lilly's GLP-1 Juggernaut Powers 48% Revenue Jump, Eyes Next Obesity Blockbuster
Companies

Eli Lilly's GLP-1 Juggernaut Powers 48% Revenue Jump, Eyes Next Obesity Blockbuster

Quarterly sales topped $23 billion as Mounjaro and Zepbound dominate the obesity drug market. With a new oral pill and a...

Declan Byrne 👁 34 💬 0
Eli Lilly's Mounjaro Hits R$13.5 Billion in First Year in Brazil, Reshaping Obesity Drug Market
Companies

Eli Lilly's Mounjaro Hits R$13.5 Billion in First Year in Brazil, Reshaping Obesity Drug Market

Demand for tirzepatide outstripped expectations, boosting the Brazilian unit into Eli Lilly's global top 10, but looming...

Declan Byrne 👁 69 💬 0
Novo Nordisk Sues Eli Lilly for ‘Deceptive’ Ads Using Outdated Dosing Data
Companies

Novo Nordisk Sues Eli Lilly for ‘Deceptive’ Ads Using Outdated Dosing Data

Novo Nordisk alleges Eli Lilly compared its drugs to lower, non-current doses of Wegovy and Ozempic in advertising, seek...

Declan Byrne 👁 36 💬 0